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E-selectin is an inducible endothelial cell adhesion protein 
that is a critical element in the binding of leukocytes to acti-
vated endothelial cells. It is induced by a variety of pro-
inflammatory soluble substances including interleukin-l 
(IL-l), tumor necrosis. factor ~TNF), or bacteriallipopol,Y-
saccharide (LPS). III Vitro studles of large vessel endothelIal 
cells demonstrate that stimulation with TNF or IL-l leads to 
a rapid, but transient, induction of E-selectin expression that 
disappears within 24 hours. However, ill vivo studies have 
shown that microvascular endothelial cells persistently ex-
press E-selectin in chronic inflammatory states, particularly 
in the skin where it serves as a homing receptor for memory T 
cells. Stimulation of dermal-derived microvascular endothe-
lial cells (HDMECs) with single doses ofIL-l a, TNF a, or 
LPS resulted in transient but slightly more persistent expres-
sion of E-selectin than seen after stimulation of large vessel 
derived umbilical vein endothelial cells (HUVECs). How-
ever, stimulation of either HDMECs or HUVECs with re-
E -selectin or endothelial leukocyte adhesion molecule 1 (ELAM-l) is an inducible endothelial cell (Ee) surface glycoprotein [1-4). It is a member of the selectin family of adhesion proteins and bears structural similarities to L-selectin (leukocyte adhesion molecule 1, LAM-1) on 
leukocytes and P-selectin on platelets and EC (GMP 140, PAGEM, 
CD62) [5) . Although E-selectin was originally described as an ad-
hesion molecule mediating the binding of neutrophils and mono-
cytes, more recently it has been shown to mediate the binding of 
memory T lymphocytes and tumor cells to ECs [6-8). Further-
more, E-selectin appears to serve as an important ligand for the 
homing ofT lymphocytes specificall y to sites of cutaneous inflam-
mation [6,9) . 
The expression of E-selectin has been studied extensively on 
human umbilical vein ECs (HUVECs) . Although not constitutively 
expressed on HUVECs, E-selectin expression can be induced by 
treatment with interleukin 1 (IL-1), tumor necrosis factor (TNF), 
and bacterial lipopolysaccharide (LPS) [1,2,10). Unlike the cyto-
kine induction of intercellular adhesion molecule 1 or vascular cell 
adhesion molecule 1, the induced expression ofE-selectin has been 
reported to be transient on HUVECs, peaking after 6 - 8 h of stimu-
lation and returning to baseline by 24 h [1,2). HUVECs are refrac-
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petitive doses of IL-la, TNFa, or LPS in the presence of 
human serum or plasma resulted in persistent E-selectin 
expression in vitro. The persistent E-selectin cell surface ex-
pression was associated with persistent E-selectin mRNA ex-
pression and correlated with E-selectin - mediated HL-60 
binding to endothelial cell monolayers. The effect of human 
plasma or serum was dose dependent, and fractionation of 
human plasma by gel filtration demonstrated that the E-se-
lectin persistence activity resolved into high and low molec-
ular peaks. These data demonstrate that human endothelial 
cells are capable of persistent E-selectin expression ill vitro and 
that factors in human serum or plasma are critical in prevent-
ing cytokine refractoriness and loss of E-selectin expression. 
This study provides a basis to resolve the apparent discrepan-
cies between previous in VillO and in vitro dynamics ofE-selec-
tin expression. Key words: E-selectin/ettdothelium/serum/ 
plasma. ] Im/est Dermatol1 02:445 -450, 1994 
tory to reinduction of E-selectin by the same stimulus prior to a 
requisite recovery period of 12 h [1 ,2) . These kinetics are not con-
sistent with observations of the in vivo expression of E-selectin in 
chronic inflammation, where E-selectin may be persistently ex-
pressed [11-13). 
We have previously examined the expression of inducible and 
constitutively expressed proteins on large-vessel HUVECs and 
small-vessel ECs derived from the dennis of human foreskin 
(HDM.Ee) and found that smalI-vessel ECs differ significantly both 
phenotYpically and functionalIy [14-16). Because the microvascu-
lar ECs of the dermis are critical in the regulation of leukocyte 
traffic into the skin, we have examined the expression of E-selectin 
in HD MECs and compared it to the regulated expression of E-se-
lectin on HUVECs. We have determined that persistent expression 
of E-selectin can be induced on either HDMECs or HUVECs in 
vitro by repetitive stimulation with cytokine in the presence of 
human plasma or serum. 
MATERIALS AND METHODS 
Isolation and Culture ofHDMECs HDMECs were isolated by from 
human foreskins by trypsinization and percoll gradient centrifugation by a 
previously described technique [14-16]. Cel ls were cultured in media 
(HDMEC media) consisting of MCDB 131 (Clonetics Corp., San Diego, 
CA), 30% normal human serum (NHS, Irvine Scientific, Santa Ana, CA), 
epider~aj growth factor (5 ng/ ml, Clonetics), hydrocortisone acetate (1 
Jlg/mj, Sigma C hemical, St. Louis, MO), dibutyryl cyclic AMP (5 X 10-5 
M, Sigma), 100 U /ml penicillin (Irvine), 100 Jlg/ ml streptomycin (Irvine), 
10 Jlgjwl ciprofloxacillin (Miles Pharmaceuticals, West Haven, CT), and 
250 Jlg/ml amphotericin B (Irvine). The resulting cell cultures were consist-
ently 100% pure as assessed by morphologic and immunochemical criteria 
[14-16]. The cells could be routinely passaged up to eight times and un-
0022-202X/94jS07.00 Copyright © 1994 by The Sociecy for Investigative Dermatology, Inc. 
445 
446 SEPP EY AL 
dergo at least 20 population doublings. All experiments were conducted 
with cells in passages 2-6. 
Isolation and Culture ofHUVECs HUVECs were isolated from colla-
genase-treated umbilical vein as describ.ed previousl~ [17] . Cells were c~l­
tured in a media (HUVEC media) conslstll1g of medIUm 199 (Irvll1e) with 
20% fetal calf serum (FCS; Irvine). EC mitogen (100 Jlg/ml; Collaborative 
Research. Cambridge. MA). heparin (50 Jlg/ml; Sigma). 2 mM glutamine 
(Irvine), 100 U/mol penicillin. 100 Jlg/ml streptomycin. and 250 Jlg/ml 
amphotericin B. 
Antibodies Monoclonal antibodies (MoAb) 7 A9 [18] recognizing E-
selectin was obtained from Dr. Walter N ewman (Otsuka America). MoAbs 
ID6 and E.12F9* were the generous gift of Dr. Barry Wolitzky (Hoffman-
LaRoche. Nutley. NJ). Hybridomas producing MoAb 84HI0 recognizing 
ICAM-1 [19] were obtained from Dr. Stephen Shaw (National Institutes of 
Health. Bethesda. MD). Hybridomas producing MoAb W6/32 recognizing 
MHC class I and OKT-ll recognizing CD2 were obtained frorn American 
Type Cell Culture (ATCC. Rockville. MD) and are routinely grown in our 
laboratory . 
Induction of E-selectin Expression on HDMECs or HUVECs and 
Measurement by Enzyme-Linked Immunosorbent Assay (ELISA) 
HDMECs or HUVECs were plated in 96-well plates and allowed to grow to 
confluence over 24 h. Cells were then stimulated with TNFa (1-100 
U/ml; Genentech, South San Francisco. CAl. IL-la (1 -100 U Iml; Dr. Ira 
Green, NIH). or LPS (1 -1000 ng/ml; Sigma). For time course studies. 
appropriate wells were stimulated with a single dose of IL-lcx. TNFa. or 
LPS sequentially and then assayed simultaneously at the conclusion of the 
time course. For studies utilizing repetitive doses of cytokine. the old media 
was removed and fresh media was added to stimulated wells at each succes-
sive time point. For example. cells initially stimulated for a 48-h time point 
were refed fresh media with cytokine 24 h later. when the next group of cells 
were stimulated for the 24-h time point. This process was repeated for the 
16-.6-.4-. and I-h time points. Therefore. the 48-h stimulated cells received 
fresh cytokine at the 24-. 16-.6-.4-. and 1-h time points. Similarly. the 24-h 
stimulated cells received fresh media with cytokine at the 16-. 6-. 4-. and I-h 
time points. The 16-. 6-, and 4-h time points were treated similarly. Each 
time. the media was removed and replaced with fresh media with cytokine. 
To. assay for expression of cell surface proteins. HDMECs or HUVECs 
were incubated with MoAb (1 Jlg/ml in Hank's balanced salt solution 
[HBSS; Irvine] with divalent cations and 5% FCS) for 1 h at 37° C. The cells 
were washed and incubated with peroxidase-conjugated goat anti-mouse 
immunoglobulin G (lgG. Biorad. Richmond. CAl diluted 1: 500 in HBSS 
with divalent cations and 5% FCS. After another incubation. the cel ls were 
again washed and the binding assessed by the addition of 100 JlI of 100 
Jlg/ml tetramethylbenzidine (Sigma) with 0.3% H20 Z in distilled water. 
The reaction was stopped by the addition of 25 Jll of 8 N sulfuric acid and 
plates were read on an E~ISA reader (Titertek Multiscan) at optical density 
(OD) 450 nm. Controls Il1cluded wells With HDMECs incubated only with 
tetramethylbenzidine. HDMECs stained with second-step antibody only. 
and HDMECs stallled With melevant monoclonal antibody (OKT 11). 
Results represent the mean of four values ± S.D. 
Isolation of Total Cellular for Northern Blot Analysis "!'otal cellular 
RNA was isolated from experimental cells by guanidinium isothiocyanate 
lysis and CsCI density gradient pelleting [20] . Equal quantities of RNA 
samples were fractionated over formaldehyde/agarose gels. transferred to 
nylon membranes (Nytran; Schleicher & Schull. Keene. NI-l). and then 
ultraviolet (UV) cross-linked to membranes using an automated UV expo-
sure device (Stratagene. La Jolla. CAl· Membranes were pre hybridized at 
42°C for 1 h or longer in a solution of 50% formamide, 1 M NaCI, 10% 
dextran sulfate. 1 % sodium dodecyl sulfate (SDS), and 200 ).lg/ml yeast 
tRNA. Membranes were hybridized overnight at 42°C with 20 ng of ran-
domly primed 32P-Iabeled cDNA fragments for the E-selectin. gene [21] (Dr. 
T . Venkat Gopal, Otsuka America Pharmaceuticals, Rockville, MD, specific 
activities 108 -1 09 cpm/ Jlg). Probed membranes were washed under increas-
ingly stringent conditions and exposed to x-ray film (Hyperfilm; Amer-
sham) with one intensifying screen at -70°C for varying till1e5."Following 
hybridization with specific cDNA probes, membranes were stripped and 
rehybridized with a p-actin cDNA fragment to assess uniformity of RNA 
loading and transfer. 
HL-60 Binding Assay The human leukemia line HL-60 was obtained 
from Dr. Ed Ades (CDC. Atlanta, GA) and was maintained in RPMI 1640 
• MoAbs E.12F9 and 1 D6 immunoprecipitate E-selectin from E-sclectin 
transfected, but not mock transfected COS cel ls. Dr. Barry Wolitzky, per-
sonal communication. 
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with 10% FCS, 2 mM glutamine, 100 U/ml penicillin, 100 Jlg/ml strepto-
mycin, and 250 Jlg/ml amphotericin B. HL-60 were radiolabeled by incuba-
tion of 5 X 107 cells in 20 ml of media with 200 uCi of 51Cr overnight at 
37°C with 5% CO2 , HDMECs were plated in 48-well tissue culture plates 
and stimulated for 1-48 h with 100Jl/ml IL-la.ln some experiments, fresh 
cytokine was added to previously stimulated wells at each subsequent time 
point (as described above). After stimulation. ECs were washed once with 
HBSS with divalent cations and 10% FCS and 50 Jll of the same media 
containing 2-4 X 104 radiolabeled HL-60 were added to each well. For 
antibody blocking experiments, HDMECs were pre incubated with MoAb 
prior to the addition of HL-60 cells. MoAb 7 A9 recognizing E-selectin was 
used at 5 Jlg/ml. Ascites containing MoAb W6/32 (recognizing MHC class 
I) or MoAb 84HI0 (recognizing ICAM-l) were used at a 1: 100 dilution. 
After incubation with HL-60 cells for 30 min at 37°C with 5% C02, the 
plates were washed twice, 50 Jll of 10% SDS was added to each well, and the 
contents of each well were harvested with a cotton swab and counted in a y 
counter (Beckman G5500). The percent binding was calculated as follows: 
o 60 b' d' cpm per well - background cpm VoHL- m mg= . 
cpm added counts - background cpm 
Fractionation of Human Plasma by Gel Filtration Human plasma 
was obtained from normal volunteers by venipuncture after informed con-
sent according to the guidelines of the Emory University Institutional Re-
view Board. Venous blood was heparinized with 100 U/ml of bovine hepa-
rin (Upjohn, Kalamazoo, MI), centrifuged. and the plasma decanted and 
saved. Five milliliters of heparinized plasma was loaded on a Sephacryl S-200 
column (Pharmacia, Uppsala, Sweden, 1.5 X 70 cm, total bed volume 105 
mI) that had been pre-equilibrated with HBSS with 1 U/ml of heparin 
sodium, divalent cations, and 5 X antibiotics, and 2-ml fractions were col-
lected. 
The activity of individual column fractions was assessed for its ability to 
facilitate IL-1a - induced persistent E-selectin expression. HUVECs were 
stimulated repetitively for 48 h with equal parts media containing 200 U /ml 
of IL-la and selected column fractions . After 48 h, the expression of E-
selectin was assessed by ELISA as described above. The protein concentration 
of each fraction was estimated by determining the OD 280 of the residual 
unused portion of each fraction. 
RESULTS 
Induction ofE-selectin on HDMECs and HUVECs with Sin-
gle Cytokine Doses Unstimulated HDMECs or HUVECs did 
not express cell surface E-selectin. Stimulation of HDMECs or 
HUVECs with a single dose of IL-1a (100 U/ml), TNFa, (100 
U /ml), or LPS (1 ).lg/ml) for 6 h induced the expression ofE-selec-
tin when assessed by ELISA or flow cytometric analysis (data not 
shown). Maximal E-selectin expression was induced by 50-100 
U/ml ofIL-la or TNFa, and 100 ng/ml ofLPS. Minimal induc-
tion ofE-selectin was seen on HDMECs (Fig lA) or HUVECs (Fig 
lB) after 1 h of stimulation with a single dose of IL-la or TNFa, 
but significant expression was always evident after 4 h. Maximal 
expression was observed in both HDMECs and HUVECs after 6 h 
of stimulation. E-selectin expression on HUVECs decreased mark-
edly after 16 h and returned to baseline after 24 h . In contrast, 
maximal or near-maximal levels of E-selectin expression were 
clearly evident on HDMECs after 16 h. Expression ofE-selectin on 
HDMECs was variable after 24 h of stimulation with IL-la or 
TNFcx, but E-selectin expression was consistently near baseline 48 h 
after stimulation with a single dose of IL-l cx or TNFa. 
Induction of Persistent E-selectin Expression on HDMECs 
with Multiple Cytokine Pulses Because of the puzzling dis-
crepancy between transient ill vitro expression and persistent itl vivo 
expression of E-selectin in cutaneous inflammation, we examined 
whether persistence of E-selectin expression could be induced on 
microvascular ECs ill vitro by repetitive dosing with cytokines. We 
compared the expression of E-selectin on HDMECs stimulated 
with a single dose of cytokine to the expression on an experimental 
group of HDMECs repetitively treated with fresh cytokine at each 
time point (Fig 2). In these experiments, maximal levels ofE-selec-
tin expression in cells stimulated with a single dose of IL-la were 
seen after 6 h of stimulation. E-selectin expression fell markedly 
after 24 h, and was essentially undetectable after 48 h. However, 
HDMECs stimulated with repetitive doses of IL-lcx demonstrated 
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Figure 1. Time course of E-selectin expression on HDMECs and 
HUVECs. A) HDMECs were stimulated with a single dose of IL-la 
(100 U I ml, opell circles) or TNFa (100 U I ml , closed circles) and E-selectin 
expression was assessed by ELISA after I , 4, 6, 16, 24, and 48 h of stimula-
tion . B) HUVECs were stimulated with a single dose ofIL-la (100 U/ ml , 
open circles) or TNFa (100 U I ml , closed circles) and E-sclectin expression was 
assessed by ELISA after I , 4, 6, 16, 24, and 48 h of stimulation. 
maximal levels ofE-selectin, which clearly persisted at 48 h. Repet-
itive stimulation of HDMECs with TN Fa or LPS also induced 
E-selectin expression, which persisted at least 48 h (data not shown) . 
In selected experiments, E-selectin expression was assayed and 
fo und still to be maximal 72 h after either IL-la, TNFa, or LPS 
stimulation (data not shown) . 
B ecause repetitive doses of cytokine were capable of inducing 
persistent E-selectin expression, the transient expression of E-selec-
tin after a single cytokine dose suggested that the fall in E-selectin 
levels may be due to loss of cytokine activity or clearance of cytokine 
by the endothelial cell monol ayers. T o investigate th ese possibili-
ties, w e stimulated HDMECs with either fresh IL-la, IL-la that 
had been incubated with HDMECs for 24 h, or IL-l a that had been 
incubated in microtiter plates without HDMECs at 3r c for 24 h 
(Fig 3). Incubation of cytokine with HDMECs resulted in greater 
than 80% loss of E-selectin-inducing activity, compared to fres h 
IL-la. In contrast, IL-la incubated withollt HDMECs demon-
strated activity comparable to fresh cytokine. These data suggest 
that endothelial cells inactivate or clear IL-la activity from the 
media, resulting effectively in a single pulse of stimulation rather 
than continuous presence of the activating cytokine. 
N orthern Blot Analysis ofHDMECs Stim.ulated with Single 
or Multiple Doses ofIL-la (Fig 4) W e explored whether per-
sistence of surface E-selectin on HDMECs with repetiti ve doses of 
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Figure 2. Persistent E-selectin expression on HDMECs requires repetitive 
IL-l a doses. HDMECs were stimulated with single doses ofIL- l a (1 00 U I 
ml) at different time points (48, 24, 16, and 6 h, opell circles) or were stimu-
lated with repetitive doses (48, 24, 16, and 6 h, closed circles), as described in 
Ma terials alld Methods. 
cytokine was accompanied by persistently elevated levels ofE-selec-
tin mRNA. Unstimu lated HDMECs did not express E-selecti n 
mRNA. Stimulation w ith IL- la resulted in express ion ofE-selectin 
mRNA that w as cl early detectable 4 h after a single dose, but was no 
longer detectable 48 h after a single IL- l a dose. In contrast , 
HDMECs stimulated with repetitive doses of IL-l a not only ex-
pressed E-selectin m RNA after 4 h of stimulation , but also expressed 
comparable E-selectin mRNA after 48 h of stimulation. 
HL-60 ~inding Assay T o determine w hether the expression of 
E-selectln o n HDMECs correlated functionally' w ith infl ammatory 
D 
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A 
0.0 0.1 0.2 0.3 
0.0. 450 nm 
Figure 3. Incubation of IL-I a with HDMECs removes E-selcctin-
inducing activi ty. E-selectin expression was assayed by ELISA on unstimu-
lated HDMECs (A) or on HDMECs incubated for 6 h with media contain-
ing fresh IL-l a (B; 100 U/ 1111), l11edia containing IL-l a (100 U/ml) that 
had been incubated with HDMEC monolayers fo r 24 hat 37"C (C), or 
media containing IL-l a (1 00 U/ I11I) that had been incubated for 24 h at 
37"C withoUI HDMEC monolayers for 24 h (D). 
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Figure 4. Northern blot analysis of E-selectin mRNA expression in 
HDMECs stimulated with IL-la. Total cellular RNA was isolated from 
unstimulated HDMECs (A), or HDMECs stimulated with a single dose of 
IL- la (100 U/ml) for 6 h (B) or 48 h (C), orwith repetitive doses ofIL-la 
over a 48-h period (D). The blot was stripped and reprobed with a cDNA for 
fJ-actin to demonstrate even loading. 
cell binding to microvascular ECs, we examined the binding of the 
HL-60 cells to cytokine-stimulated HDMECs. HL-60 cells have 
been previously shown to adhere to activated endothelial cells via an 
E-selectin-dependent mechanism [1,2] and MoAb-blocking stud-
ies clearly demonstrated that HL-60 cells bind to activated 
HDMECs via an E-selectin-dependent mechanism (Fig SA). Fur-
thermore, the binding of HL-60 cells paralleled the expression of 
E-selectin on HDMECs (Fig SB). Binding of HL-60 increased 
three- to five-fold after IL-1a stimulation and was maximal after 6 h 
after a single cytokine dose. The elevated binding persisted at maxi-
mal ·or near-maximal levels for 16 h and then fell back to baseline 
levels by 48 h. Treatment of HDMECs with repetitive cytokine 
doses resulted in persistently increased levels of HL-60 binding to 
HDMECs up to 48 h, which correlated with the persistent expres-
sion of E-selectin. 
Induction of Persistent E-Selectin Expression on HUVECs 
The induction and regulation of E-selectin on large-vessel- derived 
HUVECs has been extensively studied [1 ,2]. These studies demon-
strated that after cytokine stimulation, HUVECs exhibit a refrac-
tory period where E-selectin cannot be reinduced by the same cyto-
kine. Repetitive stimulation of HUVECs with IL-1a (100 U/ml) 
failed to induce persistent E-selectin expression (Fig 6A,B). How-
ever, when HUVECs were grown in HDMEC media or HUVEC 
media supplemented with human serum and stimulated with repet-
itive doses ofIL-1a, E-selectin expression was induced and persisted 
in a manner identical to that seen with HDMECs (Fig 6A). These 
data demonstrate that human serum provides a signal that is re-
quired for persistent IL-1 - induced expression of E-se\ectin by both 
microvascular and large-vessel ECs. Further studies determined that 
the activity was present in both human serum and plasma (Fig 6B). 
Also, HUVECs stimulated with IL-1a persistently expressed E-se-
lectin when stimulated in the presence of both FCS and human 
plasma or serum, demonstrating that FCS did not contain a factor 
that inhibited E-selectin expression (data not shown). The activity 
was dose dependent, with maximal E-selectin persistence noted 
after repetitive stimulation with cytokine in the presence of at least 
30-50% human plasma (Fig 7). 
To further characterize the nature of the factor in human plasma 
that is responsible for the E-selectin persistence, we fractionated 
human plasma by gel filtration on Sephacryl S-200 and examined 
the activity of the collected fractions (Fig 8) . HUVECs were stimu-
lated with repetitive doses of IL-la (100 U Iml) in combination 
with serum fractions and examined for E-selectin expression after 
48 h. Two peaks of E-selectin persistence activity were observed. 
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Figure 5. IL-la - dependent increases in HL-60 binding to HDMECs are 
mediated primarily via E-selectin and persistent E-selectin expression on 
HDMECs results in persistent increases in HL-60 binding. A) Binding of 
radio labeled HL-60 cells to unstimulated or stimulated (IL-la-tOO UI 
ml X 6 h) HDMECs was examined as described in Materials atld Met/lods. 
Stimulated HDMECs were either untreated (NO AD), or preincubated with 
MoAb 7 A9 recognizing E-selectin, MoAb 84HI0 recognizing ICAM-l, or 
MoAb W 6/32 recognizing MHC Class 1. B) Binding of radio labeled HL-60 
cells to HDMECs stimulated with single doses ofIL-ta (100 U/ml) (closed 
circles) versus repetitive doses (opetl circles) was examined after either 4,6, 16, 
24, or 48 h. 
The first peak was seen in the void volume of the column, suggest-
ing a molecular weight greater than 200,000. A second broad peak 
was seen after the majority of the protein has passed through the 
column. Sizing of the column demonstrated that this peak sized 
between ovalbumin (MW 45,500) and ribonuclease (MW 13,500). 
DISCUSSION 
E-selectin is an important endothelial-specific adhesion molecule 
that may mediate the binding of a variety of bone marrow-derived 
cells to activated ECs [2,6]. E-selectin was originally described as an 
inducible protein on umbilical vein-derived ECs that was rapidly 
induced, transiently expressed, and supported the binding of neu-
trophils to activated endothelium [3J . The induction of EC E-
selectin in cutaneous inflammation in vivo was associated with neu-
trophilic inflammatory cell infiltrates [1 2] . The kinetics ofE-selec-
tin expression and its affinity for neutrophils were felt to be consist-
ent with its role in mediating neutrophil binding early in the 
evolution of acute inflammation. 
More recent observations suggest that this scenerio is not ade-
quate to explain the role of E-selectin in inflammation. Immuno-
histochemical studies of chronic cutaneous and synovial inflamma-
tion clearly demonstrate that E-selectin is persistently expressed 
[12,13] . These ill vivo studies are difficult to reconcile with i/l vitro 
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Figure 6. Human serum or plasma is necessary for persistent E-selectin 
expression by ECs. A) HVVECs were stimulated with multiple doses of 
IL-la (100 Vjml) in HDMEC media (opell circles), HVVEC media (closed 
circles), or HVVEC media with 30% human serum substituted for fetal calf 
serum (oletl triallgles) . B) HVVECs were repetitively stimulated with IL-1a 
(100 Vjml) in HVVEC media with 20% FCS (opell circles) or the same 
media with 30% normal human plasma in addition to FCS (closed circles). 
observations demonstrating that E-selectin can only be transiently 
induced on ECs in culture. Additionally, E-selectin has also been 
shown to mediate the binding of leukocytes other than neutrophils. 
In particular, memory T lymphocytes are able to bind to E-selectin 
and E-selectin may function as a homing receptor for specific resting 
meInory T-cell subsets, directing their localization to cutaneous 
inflammatory sites [6,7,9]. 
The original ill vitro studies of the expression of E-selectin dem-
onstrated that it was only transiently expressed despite the apparent 
continuous presence of cytokines [1,2] . Furthermore, experiments 
using multiple cytokine pulses demonstrated the presence of a re-
fractory period in which E-selectin could not be induced by the 
saIne cytokine without a requisite recovery period of 12 h [1 ,2] . 
IFN -y has been shown to nominally prolong the expression of E-
selectin on HUVECs in vitro, although in these studies the expres-
sion of E-selectin still fell to near baseline after 48 h [23]. Further-
more, subsequent studies suggested that IFN-y augments cytokine-
induced E-selectin expression and also inhibits the refractory period 
after LPS stimulation, although data regarding the refractory period 
after IL-l and TNF stimulation were not presented [23] . 
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Figure 7. Plasma-rtlediated E-selectin persistence itl vitro: dose dependence. 
HVVECs were stimulated repetitively with IL-1a (100 Vjm!) for 48 h (at 
6, 16, 24. and 48 h) in the presence of increasing concentrations of human 
plasma and assayed for E-selectin expression by ELISA, as described in 
Materials alld Methods. 
The persistent responsiveness to cytokine stimulation that we 
observed itl vitro correlates with in villo observations of E-selectin 
expression in chronic inflammation. Our data demonstrate that 
under the correct in vitro conditions, E-selectin can be induced and 
its expression and function will chronically persist at essentially 
maximal levels on ECs in culture. This persistence is not due to 
inherent differences in ECs derived from different vascular beds, as 
has been described with VCAM-l and CD36 [15,16]. Persistent 
E-selectin expression requires both repetitive cytokine stimulation 
and, additionally, persistent expression depends upon the growth of 
EC:s in.media containing hU~1an serum or plasm~. Repetitive stimu-
lation IS necessary because smgle doses of cytokmes appear rapidly 
cleared or inactivated by ECs. It is likely that the inflammatory cells 
characteristically found at sites of chronic inflammation in the skin 
or joints may serve as a source of repetitive cytokine stimulation for 
ECs, a situation in vivo approximated by our it! vitro model utilizing 
repetitive cytokine doses. Histologic and immunohistochemical 
studies of chronic inflammation, as is seen in psoriasis, rheumatoid 
arthritis, or delayed hypersensitivity reactions, are characterized by 
both perivascular lymphocytic infiltrates and chronic E-selectin ex-
pression [12,13]. 
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Figure 8. Fractionat-jon of human plasma by gel filtration on Sephacryl 
S-200. Five milliliter:s of heparinized human plasma was separated by gel 
filtration and the elut~d fractions tested for their ability to permit persistent 
E-selectin expression -with repeated IL-IO! (100 Vjml) stimulation, as de-
scribed in Materials alld Methods (see Fractionation of Human Plasma by Gel 
Filtration). E-selectin expression (opell bars) was determined by ELISA and 
expressed as 00 450 I:}rn (left axis) and protein concentration of the fractions 
(closed circles) was det~f'mined by OD 280 nm (right axis). 
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The second factor that plays a role in E-selectin persistence is a 
constituent of human serum or plasma. Repetitive stimulation alone 
is not sufficient to permit chronic E-selectin expression because ECs 
become refractory to cytokine effect. Culture oflarge- or small-ves-
sel ECs in the presence of human serum or plasma is permissive for 
the continuous expression ofE-selectin. In the presence of factors in 
human serum or plasma, the continuous pulsing of ECs with cyto-
kine in vitro results in persistent E-selectin expression. Evidence 
from Northern blot analysis demonstrates that the effect occurs at 
the level of mRNA expression. It is possible that the factor affects 
cytokine-mediated transcriptional events, mRNA stability, or both. 
The exact nature of the factor or factors present in human serum and 
plasma that mediate this effect is not fully characterized. The repet-
itive stimulation of endothelial cells with plasma fractions separated 
by gel filtration of plasma demonstrated two peaks of activity, sug-
gesting that either two factors may mediate this effect, or a single 
small molecular weight factor that may associate with a large carrier 
protein may be responsible. Characterization of this factor or factors 
and their interaction with endothelial cells or cytokines is currently 
under investigation. 
This study serves to reconcile in vivo and in vitro data regarding 
E-selectin induction and persistence on ECs, points to overall simi-
larities between large- and small-vessel ECs in E-selectin regulation, 
and indicates a critical role for factor(s) in human plasma in this 
process. Identification of such factor(s) will likely help clarify and 
better define the mechanisms by which E-selectin expression is 
induced and maintained in vascular endothelial cells. Furthermore, 
these data suggest that in vitro models and culture systems that more 
closely approximate in vivo conditions may be preferable in deter-
mining the fine regulation of these critical proteins. 
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